$CLBS just temember, $2.10/share cash, MANY irons in the fire in diverse focuses, and with damaged tissue regeneration, they could surprise PR with new development at anytime, especially now, with all the cash!! Think of the possibilities for diabetes, all the afflictions from poor circulation (more practical), etc...OR some surprise thing to help regenerate and repair tissue damage from covid associated kidney and lung complications (more hype). Even if they dont, they have a promising pipeline,albeit major updates not anticipated in near term, hence the price. However, big surprise PR often have the biggest returns, especially if unservalued and heqvily shorted while being steered by the big offering buying tutes. Things to keep in mind. Always diversify!! Cheers!